Patients with pancreatic cancer are needed for a study to research a combination of experimental immunotherapy, chemoradiation and surgery

IRB/UVA Tracking #
22011
Principal Investigator
Tri M Le
Contact
Sallie Mannen
Contact Email
Contact Phone
434.297.5724
Official Trial Title
Neoadjuvant GMCI Plus Chemoradiation For Advanced Non-Metastatic Pancreatic Adenocarcinoma
Study Description

The University of Virginia Cancer Center is conducting a clinical research study for adult patients ages 18 and over, with pancreatic cancer. The purpose of this study is to evaluate safety and effectiveness of an experimental drug (AdV-tk + valacyclovir) in combination with standard of care chemoradiation and surgery.

Participation will take approximately 3 months for the treatment phase, with a longer term follow-up via a clinic visit or a phone call to keep track of how you’re doing. Study specific tests will be provided at no cost to you.

Additional information can be found here: https://clinicaltrials.gov/ct2/show/NCT02446093

Compensation

You will receive compensation for your travel and time in this study.